130 related articles for article (PubMed ID: 6533395)
1. Recovery of cortical phospholipidosis and necrosis after acute gentamicin loading in rats.
Giuliano RA; Paulus GJ; Verpooten GA; Pattyn VM; Pollet DE; Nouwen EJ; Laurent G; Carlier MB; Maldague P; Tulkens PM
Kidney Int; 1984 Dec; 26(6):838-47. PubMed ID: 6533395
[TBL] [Abstract][Full Text] [Related]
2. Protection against gentamicin-induced early renal alterations (phospholipidosis and increased DNA synthesis) by coadministration of poly-L-aspartic acid.
Beauchamp D; Laurent G; Maldague P; Abid S; Kishore BK; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):858-66. PubMed ID: 2243354
[TBL] [Abstract][Full Text] [Related]
3. A 2'guanidyl derivative of gentamicin (S86451) with reduced nephrotoxicity studies at low and medium dose levels in the rat.
Maldague P; Laurent G; Carlier MB; Tulkens P
Arch Toxicol Suppl; 1984; 7():455-8. PubMed ID: 6596014
[TBL] [Abstract][Full Text] [Related]
4. Tubular injury and regeneration in the rat kidney following acute exposure to gentamicin: a time-course study.
Nonclercq D; Wrona S; Toubeau G; Zanen J; Heuson-Stiennon JA; Schaudies RP; Laurent G
Ren Fail; 1992; 14(4):507-21. PubMed ID: 1462002
[TBL] [Abstract][Full Text] [Related]
5. Cationic amphiphilic drug-induced renal cortical lysosomal phospholipidosis: an in vivo comparative study with gentamicin and chlorphentermine.
Kacew S
Toxicol Appl Pharmacol; 1987 Dec; 91(3):469-76. PubMed ID: 3424375
[TBL] [Abstract][Full Text] [Related]
6. Age-dependent gentamicin experimental nephrotoxicity.
Beauchamp D; Gourde P; Thériault G; Bergeron MG
J Pharmacol Exp Ther; 1992 Feb; 260(2):444-9. PubMed ID: 1738093
[TBL] [Abstract][Full Text] [Related]
7. Apoptosis in renal proximal tubules of rats treated with low doses of aminoglycosides.
El Mouedden M; Laurent G; Mingeot-Leclercq MP; Taper HS; Cumps J; Tulkens PM
Antimicrob Agents Chemother; 2000 Mar; 44(3):665-75. PubMed ID: 10681336
[TBL] [Abstract][Full Text] [Related]
8. Nephrotoxicity of gentamicin.
Kosek JC; Mazze RI; Cousins MJ
Lab Invest; 1974 Jan; 30(1):48-57. PubMed ID: 4812808
[No Abstract] [Full Text] [Related]
9. Induction of nephrotoxicity by high doses of gentamicin in diabetic rats.
Ramsammy LS; Josepovitz C; Jones D; Ling KY; Lane BP; Kaloyanides GJ
Proc Soc Exp Biol Med; 1987 Dec; 186(3):306-12. PubMed ID: 3423018
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. II. Comparative in vitro and in vivo studies with poly-L-aspartic, poly-L-glutamic and poly-D-glutamic acids.
Kishore BK; Lambricht P; Laurent G; Maldague P; Wagner R; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):875-85. PubMed ID: 1700819
[TBL] [Abstract][Full Text] [Related]
11. Impairment of lysosome-pinocytic vesicle fusion in rat kidney proximal tubules after treatment with gentamicin at low doses.
Giurgea-Marion L; Toubeau G; Laurent G; Heuson-Stiennon JA; Tulkens PM
Toxicol Appl Pharmacol; 1986 Nov; 86(2):271-85. PubMed ID: 3787625
[TBL] [Abstract][Full Text] [Related]
12. Tissue repair in rat kidney cortex after short treatment with aminoglycosides at low doses. A comparative biochemical and morphometric study.
Toubeau G; Laurent G; Carlier MB; Abid S; Maldague P; Heuson-Stiennon JA; Tulkens PM
Lab Invest; 1986 Apr; 54(4):385-93. PubMed ID: 3959542
[TBL] [Abstract][Full Text] [Related]
13. Protection against gentamicin nephrotoxicity by daptomycin in nephrectomized rats.
Thibault N; Grenier L; Simard M; Bergeron MG; Beauchamp D
Life Sci; 1995; 56(22):1877-87. PubMed ID: 7746096
[TBL] [Abstract][Full Text] [Related]
14. Failure of inhibition of lipid peroxidation by vitamin E to protect against gentamicin nephrotoxicity in the rat.
Ramsammy LS; Josepovitz C; Ling KY; Lane BP; Kaloyanides GJ
Biochem Pharmacol; 1987 Jul; 36(13):2125-32. PubMed ID: 3111476
[TBL] [Abstract][Full Text] [Related]
15. Mechanism of protection afforded by polyaspartic acid against gentamicin-induced phospholipidosis. I. Polyaspartic acid binds gentamicin and displaces it from negatively charged phospholipid layers in vitro.
Kishore BK; Kállay Z; Lambricht P; Laurent G; Tulkens PM
J Pharmacol Exp Ther; 1990 Nov; 255(2):867-74. PubMed ID: 2243355
[TBL] [Abstract][Full Text] [Related]
16. Experimental studies on nephrotoxicity of aminoglycosides at low doses. Mechanisms and perspectives.
Tulkens PM
Am J Med; 1986 Jun; 80(6B):105-14. PubMed ID: 3728522
[TBL] [Abstract][Full Text] [Related]
17. Attenuation by daptomycin of gentamicin-induced experimental nephrotoxicity.
Thibault N; Grenier L; Simard M; Bergeron MG; Beauchamp D
Antimicrob Agents Chemother; 1994 May; 38(5):1027-35. PubMed ID: 8067733
[TBL] [Abstract][Full Text] [Related]
18. Tubular regeneration in rat kidney cortex during treatment with gentamicin at a low dose.
Laurent G; Toubeau G; Maldague P; Carlier MB; Heuson-Stiennon JA; Tulkens P
Arch Toxicol Suppl; 1984; 7():459-63. PubMed ID: 6596015
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of aminoglycoside-induced lysosomal phospholipidosis: in vitro and in vivo studies with gentamicin and amikacin.
Laurent G; Carlier MB; Rollman B; Van Hoof F; Tulkens P
Biochem Pharmacol; 1982 Dec; 31(23):3861-70. PubMed ID: 7159463
[TBL] [Abstract][Full Text] [Related]
20. Choice of drug and dosage regimen. Two important risk factors for aminoglycoside nephrotoxicity.
De Broe ME; Giuliano RA; Verpooten GA
Am J Med; 1986 Jun; 80(6B):115-8. PubMed ID: 3728523
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
